Skopos Labs, Inc. Viatris Inc Transaction History
Skopos Labs, Inc.
- $453 Million
- Q1 2025
A detailed history of Skopos Labs, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Skopos Labs, Inc. holds 16,391 shares of VTRS stock, worth $142,437. This represents 0.03% of its overall portfolio holdings.
Number of Shares
16,391
Previous 6,826
140.13%
Holding current value
$142,437
Previous $84,000
69.05%
% of portfolio
0.03%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding VTRS
# of Institutions
1,136Shares Held
953MCall Options Held
4.15MPut Options Held
2.65M-
Vanguard Group Inc Valley Forge, PA145MShares$1.26 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$805 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD74.5MShares$647 Million0.08% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az64.9MShares$564 Million3.35% of portfolio
-
State Street Corp Boston, MA61.5MShares$534 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $10.5B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...